The doughnut giant has agreed to a multimillion-dollar settlement following a 2024 cyberattack that compromised personal data of current and former staff, though it admits no fault.
An unexpected jump in the Producer Price Index for December underscores the stubborn nature of inflation, with rising wholesale costs threatening to ripple through the economy and sustain higher prices for households.
Congress has approved $23 billion in initial funding for the ambitious Golden Dome missile defense initiative, yet the absence of a detailed spending blueprint from the Pentagon is stalling progress and clouding investment prospects for 2026.
Pharmaceutical leader Eli Lilly will build a new manufacturing facility in Lehigh County, marking the largest life sciences investment in Pennsylvania history and bolstering U.S. production of next-generation weight-loss drugs.
As SpaceX targets a record-shattering IPO for mid-2026, reports indicate Elon Musk is exploring a potential merger with either Tesla or his AI startup, xAI. The move could create a unified tech and industrial behemoth but faces significant regulatory and operational hurdles.
Eli Lilly announces a massive new manufacturing facility in Pennsylvania, part of a strategic pivot by major drugmakers to onshore production amid trade tensions and soaring demand for weight-loss drugs.
With rising demand, grid investments, and volatile fuel costs, electricity prices are outpacing wage growth, squeezing not just low-income but now middle-class households. Policy interventions face long lead times, leaving little hope for near-term bill relief.
In a significant diplomatic move, Lebanon's Cabinet has approved an agreement to repatriate hundreds of Syrian prisoners, addressing a major point of contention as the two nations navigate a new political reality following the 2024 ouster of Bashar al-Assad.
Popular, Inc. (BPOP) shares have rallied following robust 2025 results, driven by higher net interest income, EPS growth, and aggressive shareholder returns via dividends and buybacks. With the stock up nearly 20% in 90 days, investors are weighing whether its current valuation still offers an entry point.
Verizon Communications posts its strongest customer gains since 2019, bolstered by a key fiber acquisition and a renewed strategic focus under CEO Hans Vestberg, signaling a potential inflection point for the telecom giant.
A patent lawsuit filed by Solos Technology against Meta Platforms, Oakley, and EssilorLuxottica targets core smart glasses technology, posing significant risks to Meta's wearables strategy and valuation.
Following a period of strong sales growth, Chili's Grill & Bar is laying the groundwork to potentially grant its general managers a greater ownership stake, a move inspired by industry leaders like Texas Roadhouse and Raising Cane's.
ExxonMobil and Chevron signal that significant investment in Venezuela's vast oil reserves hinges on clearer legal and fiscal stability, despite recent political changes and White House pressure.
The historic Farmers' Almanac, famed for its secret weather formula, has been acquired by digital media company Unofficial Networks. The move saves the publication from shuttering, relocates its operations from Maine to New York, and promises a digital-first revival alongside a planned return to print.
Financial planners are urging a shift in mindset: the date on your retirement party invitation matters less than the balance in your investment portfolio. We break down the calculations that show whether you're truly ready to leave the workforce.
HSBC has raised its rating on New Oriental Education & Technology Group (NYSE: EDU) from 'Hold' to 'Buy', following the company's better-than-expected Q2 FY2026 results. The upgrade highlights a robust recovery in core businesses and strategic expansion into new educational initiatives.
A couple earning $380,000 annually faces a classic high-cost dilemma: Should they stretch for a $1.8 million dream home now or wait? With a hefty down payment saved but significant student debt, their debate highlights the tension between future earnings potential and present financial anxiety in today's premium housing markets.
ExxonMobil has begun commercial operations of a significant carbon capture and storage venture with CF Industries in Louisiana, marking a key step in its strategy to become a leading player in the emerging CCS network along the U.S. Gulf Coast.
Regeneron Pharmaceuticals is positioning its experimental obesity drug, olatorepatide, as a potential game-changer by combining significant weight loss with a dramatic reduction in 'bad' cholesterol. The company believes this dual benefit could carve out a unique niche in the competitive $150 billion market, currently led by Novo Nordisk and Eli Lilly.
Chevron capped off a year of strategic execution with record global production and industry-leading free cash flow growth, while outlining ambitious expansion plans from the Caspian to the Caribbean.
